hydralazine has been researched along with Chromosome-Defective Micronuclei in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martelli, A | 1 |
| Allavena, A | 1 |
| Campart, GB | 1 |
| Canonero, R | 1 |
| Ghia, M | 1 |
| Mattioli, F | 1 |
| Mereto, E | 1 |
| Robbiano, L | 1 |
| Brambilla, G | 1 |
1 other study available for hydralazine and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
In vitro and in vivo testing of hydralazine genotoxicity.
Topics: Adult; Aged; Animals; Biotransformation; Cells, Cultured; DNA Damage; DNA Repair; Female; Humans; Hy | 1995 |